En patient behandlet under et “ compassionate use program ” døde af cerebral infarkt på grund af leukocytose efter behandling med kemoterapeutika for at sænke WBC- tallet.
One patient treated under a compassionate use program died from cerebral infarct due to leukocytosis, following treatment with chemotherapeutic medicinal products to lower WBC count.